Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up

Osteoarthritis and Cartilage

Volumn 21, Issue 6, 2013, Pages 823-830

  Vos, P A J M ^a,b   Welsing, P M J ^a   deGroot, J ^c   Huisman, A M ^d   Oostveen, J C M ^e   Reijman, M ^f   Damen, J ^f   Mastbergen, S C ^a   Lafeber, F P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c TNO   (Netherlands)

^d Sint Franciscus Gasthuis   (Netherlands)

^e TWENTEBORG HOSPITAL   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CHECK; Cohort; Glycation; Osteoarthritis; Pentosidine

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; CREATININE; PENTOSIDINE;

ADULT; AGED; ALTMAN SCORE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIP OSTEOARTHRITIS; HIP RADIOGRAPHY; HUMAN; KELLGREN AND LAWRENCE SCORE; KIDNEY FUNCTION; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MALE; OSTEOPHYTE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SCORING SYSTEM; SKIN; TISSUE LEVEL;

AGED; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN TYPE II; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYSINE; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OSTEOPHYTE; SKIN;

EID: 84877140235     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.03.006     Document Type: Article

References (34)

1. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 2004, 4:301-305.
2. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Bank R.A., Lafeber F.P., Bijlsma J.W., et al. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum 2001, 44:2562-2571.
3. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002, 46:114-123.
4. Verzijl N., DeGroot J., Thorpe S.R., Bank R.A., Shaw J.N., Lyons T.J., et al. Effect of collagen turnover on the accumulation of advanced glycation end products. JBiol Chem 2000, 275:39027-39031.
5. Chen A.C., Temple M.M., Ng D.M., Verzijl N., DeGroot J., TeKoppele J.M., et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage. Arthritis Rheum 2002, 46:3212-3217.
6. Verbruggen G., Cornelissen M., Almqvist K.F., Wang L., Elewaut D., Broddelez C., et al. Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes. Osteoarthritis Cartilage 2000, 8:170-179.
7. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Jacobs K.M., Van El B., Van Roermund P.M., et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 2004, 50:1207-1215.
8. Mastbergen S.C., Marijnissen A.C., Vianen M.E., Van Roermund P.M., Bijlsma J.W., Lafeber F.P. The canine 'groove' model of osteoarthritis is more than simply the expression of surgically applied damage. Osteoarthritis Cartilage 2006, 14:39-46.
9. Vos P.A., DeGroot J., Barten-van Rijbroek A.D., Zuurmond A.M., Bijlsma J.W., Mastbergen S.C., et al. Elevation of cartilage AGEs does not accelerate initiation of canine experimental osteoarthritis upon mild surgical damage. JOrthop Res 2012, 30:1398-1404.
10. Vos P.A., DeGroot J., Huisman A.M., Oostveen J.C., Marijnissen A.C., Bijlsma J.W., et al. Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK). Osteoarthritis Cartilage 2010, 18:1329-1336.
11. van Spil W.E., DeGroot J., Lems W.F., Oostveen J.C., Lafeber F.P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18:605-612.
12. Garnero P., Aronstein W.S., Cohen S.B., Conaghan P.G., Cline G.A., Christiansen C., et al. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Osteoarthritis Cartilage 2008, 16:660-666.
13. Dam E.B., Loog M., Christiansen C., Byrjalsen I., Folkesson J., Nielsen M., et al. Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers. Arthritis Res Ther 2009, 11:R115.
14. van Tuyl L.H., Lems W.F., Voskuyl A.E., Kerstens P.J., Garnero P., Dijkmans B.A., et al. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial. Ann Rheum Dis 2008, 67:1574-1577.
15. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
16. Altman R.D., Gold G.E. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007, 15(Suppl A):A1-A56.
17. Wesseling J., Dekker J., van den Berg W.B., Bierma-Zeinstra S.M., Boers M., Cats H.A., et al. CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. Ann Rheum Dis 2009, 68:1413-1419.
18. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000, 350(Pt 2):381-387.
19. Bank R.A., Jansen E.J., Beekman B., te Koppele J.M. Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. Anal Biochem 1996, 240:167-176.
20. van Spil W.E., Drossaers-Bakker K.W., Lafeber F.P. Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis. Ann Rheum Dis 2013, 72:29-36.
21. Thornalley P.J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003, 375:581-592.
22. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function - measured and estimated glomerular filtration rate. NEngl J Med 2006, 354:2473-2483.
23. Buckland-Wright J.C., Wolfe F., Ward R.J., Flowers N., Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. JRheumatol 1999, 26:2664-2674.
24. Lequesne M.G., Laredo J.D. The faux profil (oblique view) of the hip in the standing position. Contribution to the evaluation of osteoarthritis of the adult hip. Ann Rheum Dis 1998, 57:676-681.
25. Bay-Jensen A.C., Andersen T.L., Charni-Ben Tabassi N., Kristensen P.W., Kjaersgaard-Andersen P., Sandell L., et al. Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 2008, 16:615-623.
26. Matsumoto T., Tsurumoto T., Baba H., Osaki M., Enomoto H., Yonekura A., et al. Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatol Int 2007, 28:157-160.
27. Verzijl N., Bank R.A., TeKoppele J.M., DeGroot J. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 2003, 15:616-622.
28. Felson D.T., Gale D.R., Elon Gale M., Niu J., Hunter D.J., Goggins J., et al. Osteophytes and progression of knee osteoarthritis. Rheumatology (Oxford) 2005, 44:100-104.
29. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635.
30. Li X., Kim K.W., Cho M.L., Ju J.H., Kang C.M., Oh H.J., et al. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Immunol Lett 2010, 127:100-107.
31. Steenvoorden M.M., Huizinga T.W., Verzijl N., Bank R.A., Ronday H.K., Luning H.A., et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006, 54:253-263.
32. van der Kraan P.M., van den Berg W.B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 2007, 15:237-244.
33. Wright A.A., Cook C., Abbott J.H. Variables associated with the progression of hip osteoarthritis: a systematic review. Arthritis Rheum 2009, 61:925-936.
34. Yusuf E., Bijsterbosch J., Slagboom P.E., Kroon H.M., Rosendaal F.R., Huizinga T.W., et al. Association between several clinical and radiological determinants with long-term clinical progression and good prognosis of lower limb osteoarthritis. PLoS One 2011, 6:e25426.